Conquering Diseases

Study Of An Investigational Drug Added To Usual Treatment For Relapsed Or Refractory Multiple Myeloma


Seeking men and women whose multiple myeloma has returned or has not responded to their most recent treatment for a study adding an investigational drug to the usual treatment.


Participants in this study will be randomly assigned to receive either an investigational drug combination or the usual treatment.

What we're hoping for

We are studying whether adding an investigational drug to the usual treatment for multiple myeloma that has recurred or has not responded to the most recent treatment is safe and effective in decreasing myeloma cancer cells.

Additional Information Identifier: NCT04975997

 Principal Investigator

Muthalagu  Ramanathan, MD

UMass Memorial Health

 Study Contact

The Cancer  Research Office



UMass Chan University Campus

55 Lake Ave North 

Worcester,MA 01655